Figure 3
Figure 3. Schematic representation of the different molecular events during progression of CML, supporting the co-occurrence of mutated RUNX1 alleles on one chromosome 21q22 and on the derived chromosome 1p36 harboring the RUNX1-PRDM16 fusion (example of UPN 11). (A) Sequencing data of the L29S mutation. Left: DNA-sequencing electrophoregram revealing the L29S mutation at 2/3 level. Right: RNA-sequencing electrophoregram of the full RUNX1 revealing the L29S mutation at 1/2 level. (B) Scenario of genetic and chromosomal events during the disease progression. Red cross: the mutated RUNX1 allele. Green cross: the remaining 3′ region of truncated RUNX1 gene after t(1;21)(p36;q22). (C) Representation of the corresponding various alleles of RUNX1 (white open bar) and PRDM16 (gray open bar) during CML course.

Schematic representation of the different molecular events during progression of CML, supporting the co-occurrence of mutated RUNX1 alleles on one chromosome 21q22 and on the derived chromosome 1p36 harboring the RUNX1-PRDM16 fusion (example of UPN 11). (A) Sequencing data of the L29S mutation. Left: DNA-sequencing electrophoregram revealing the L29S mutation at 2/3 level. Right: RNA-sequencing electrophoregram of the full RUNX1 revealing the L29S mutation at 1/2 level. (B) Scenario of genetic and chromosomal events during the disease progression. Red cross: the mutated RUNX1 allele. Green cross: the remaining 3′ region of truncated RUNX1 gene after t(1;21)(p36;q22). (C) Representation of the corresponding various alleles of RUNX1 (white open bar) and PRDM16 (gray open bar) during CML course.

Close Modal

or Create an Account

Close Modal
Close Modal